If you liked this article you might like

Mylan: 1 of 2 Beaten-Down Biopharmas to Buy
Retrophin (With Help From Martin Shkreli) Advances Drug for Rare Kidney Disease
Analysts' Actions -- ConocoPhillips, Discover, DineEquity, Maxim and More
Trade-Ideas: Ligand Pharmaceuticals (LGND) Is Today's Weak On High Relative Volume Stock